A comparative study of the efficacy and outcome of methylprednisolone and dexamethasone in moderate to severe COVID-19 disease
Background: COVID-19 disease is caused by severe acute respiratory syndrome corona virus 2 (SARS-CoV-2). In the first half of 2020 COVID-19 disease has already converted into a global pandemic. Many treatment options were explored through the world. Aims and Objectives: To compare the efficacy an...
Guardado en:
Autores principales: | Praveen B Gautam, Arunesh Kumar, Babu Lal Kannojia, Rajendra Chaudhary |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Manipal College of Medical Sciences, Pokhara
2021
|
Materias: | |
Acceso en línea: | https://doi.org/10.3126/ajms.v12i12.39294 https://doaj.org/article/b382186b54ce44858a71abb5ff45010a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The Effect of a Combined Ganciclovir, Methylprednisolone, and Immunoglobulin Regimen on Survival and Functional Outcomes in Patients With Japanese Encephalitis
por: Wang Miao, et al.
Publicado: (2021) -
Corticosteroids for treatment of COVID-19: effect, evidence, expectation and extent
por: Vijay K. Patel, et al.
Publicado: (2021) -
The Application of Methylprednisolone Nanoscale Zirconium-Porphyrin Metal-Organic Framework (MPS-NPMOF) in the Treatment of Photoreceptor Degeneration
por: Wang Y, et al.
Publicado: (2019) -
Reumatismo palindrómico (Enfermedad de Hench Rosemberg): Caso clínico con respuesta a los glucocorticoides
por: FINN,BÁRBARA C, et al.
Publicado: (2010) -
Porous Se@SiO2 nanocomposites protect the femoral head from methylprednisolone-induced osteonecrosis
por: Deng G, et al.
Publicado: (2018)